FAQs on Emphysema
1. What is the difference between emphysema and COPD?
Comparing emphysema vs COPD, COPD is an umbrella term for chronic lung diseases that block airflow, including emphysema and chronic bronchitis. Emphysema specifically means damage to the air sacs. Most people with emphysema have COPD, though not everyone with COPD has emphysema.
2. What are the first signs of emphysema?
The earliest signs are often subtle, mainly shortness of breath during physical activity and unusual fatigue. Some people also notice a mild cough or wheezing. Many people do not notice symptoms until about half their lung tissue is already affected.
3. Is emphysema a curable condition?
There is currently no emphysema cure, as the lung damage is permanent and cannot be reversed. However, treatments including medications, oxygen therapy, pulmonary rehabilitation, and lifestyle changes can effectively manage symptoms and significantly slow down disease progression.
4. Can non-smokers develop emphysema?
Yes, non-smoker emphysema does occur. While smoking causes most cases, secondhand smoke, long-term air pollution, occupational dust or fume exposure, and the genetic condition alpha-1 antitrypsin deficiency can all lead to emphysema even in people who have never smoked.
5. How does emphysema affect daily activities and exercise?
Emphysema life expectancy and quality of life are closely tied to how well symptoms are managed. Shortness of breath can make exercise and daily tasks more tiring, but pulmonary rehabilitation and pacing techniques help many patients remain active and independent.
6. What is the life expectancy of someone with emphysema?
Life expectancy depends on the stage and how well the condition is managed. Many people live for decades after diagnosis, especially with early treatment. Emphysema complications in advanced stages, such as severe breathing difficulty, can shorten life expectancy by several years.
7. What are the 4 types of emphysema?
The four main types are centrilobular, mainly linked to smoking and affecting the upper lungs, panlobular, linked to alpha-1 antitrypsin deficiency, paraseptal, affecting the outer lung areas, and bullous emphysema, where large air pockets form and may require surgery.
Content is medically reviewed by:
Shruti Bangera, Masters In Neurological Physiotherapy, Senior Physiotherapist & SME, Portea